Fagron TrichoTest™
Genetic test for alopecia (hair loss).
The Fagron TrichoTest™ is a state-of-the-art DNA microarray genetic test with more than 50 published studies to support its scientific basis. It individualizes and improves treatment efficacy by analyzing 48 genetic variants in the 13 genes that have been scientifically proven to be associated with hair loss.
Genetics and hair loss.
Alopecia (hair loss) is a gradual and multifactorial condition, determined by a combination of both intrinsic (genetic) and extrinsic factors (diet, stress, iron/vitamin/mineral deficiency, medication, etc.). Especially in Androgenetic Alopecia, the main cause of thinning and hair loss is hereditary, i.e. it is related to genes and their expression. In other words, there are genes which are passed on from our ancestors and which predisposes to hair loss potentially starting at a young age.
Personalized treatment of hair loss.
Advanced, safe and reliable personalised treatment of alopecia, based on the patient's genetic profile and clinical data.
Fagron TrichoTestis a state-of-the-art microarray genetic test DNA with 99.9% efficiency in genetic identification. 48 genetic variants in 13 genes that have been scientifically proven to be associated with hair loss are analysed.
The one-off test is completely painless for the patient, as it is used DNA from saliva cells collected by the dermatologist with a cotton swab (sterile swab) from the inside of the cheek (cheek).
Thus, by combining the analysis of genetic factors, clinical examination and medical history, a full understanding of the factors leading to the development of alopecia is achieved and the dermatologist is able to propose a comprehensive personalised treatment with specific therapeutic substances that will be more effective and in a dosage tailored to each patient.
Personalised medicines (galenical preparations) are prepared by your pharmacist.
Have you tried various hair loss treatments to no avail?
Advantages
- Allows the precise selection of the most effective active substances and in the appropriate dosage for the treatment of hair loss for each patient individually, saving time and costs on treatments that the patient may not respond to
- It is a non-invasive, reliable, one-time test
- It is characterised by an efficiency of 99,9% in genetic identification
- Thanks to a proven, patent-pending algorithm, a personalised treatment is achieved from a pool of >175 million alternative treatments
English 
Greek